beta-naphthoflavone has been researched along with Idiopathic Parkinson Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiaino, E; Davey, GP; Fernandez-Abascal, J; Frosini, M; Valoti, M | 1 |
| Das, NP; Moochhala, SM; Shahi, GS | 1 |
2 other study(ies) available for beta-naphthoflavone and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
β-Naphthoflavone and Ethanol Reverse Mitochondrial Dysfunction in A Parkinsonian Model of Neurodegeneration.
Topics: 1-Methyl-4-phenylpyridinium; Apoptosis; beta-Naphthoflavone; Cell Line, Tumor; Cell Survival; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2E1; Ethanol; Humans; Kinetics; Membrane Potential, Mitochondrial; Mitochondria; Neurodegenerative Diseases; Neuroprotective Agents; Parkinson Disease; Protein Isoforms; Reactive Oxygen Species; Xenobiotics | 2020 |
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity: partial protection against striato-nigral dopamine depletion in C57BL/6J mice by cigarette smoke exposure and by beta-naphthoflavone-pretreatment.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Benzoflavones; beta-Naphthoflavone; Corpus Striatum; Cytochrome P-450 CYP1A1; Cytochrome P-450 Enzyme System; Dopamine; Liver; Mice; Mice, Inbred C57BL; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Nervous System; Nicotiana; Oxidoreductases; Parkinson Disease; Plants, Toxic; Smoke | 1991 |